<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0012115'>Hepatitis</z:hpo> C virus (HCV) and <z:hpo ids='HP_0012115'>hepatitis</z:hpo> B virus (HBV) have been associated with <z:e sem="disease" ids="C0376544" disease_type="Neoplastic Process" abbrv="">hematopoietic malignancies</z:e>, but data for many subtypes are limited </plain></SENT>
<SENT sid="1" pm="."><plain>From the U.S </plain></SENT>
<SENT sid="2" pm="."><plain>Surveillance, Epidemiology, and End Results-Medicare database, we selected 61,464 cases (&gt; or = 67 years) with <z:e sem="disease" ids="C0376544" disease_type="Neoplastic Process" abbrv="">hematopoietic malignancies</z:e> and 122,531 population-based controls, frequency-matched by gender, age, and year (1993--2002) </plain></SENT>
<SENT sid="3" pm="."><plain>Logistic regression was used to compare the prevalence of HCV, HBV, and alcoholic <z:hpo ids='HP_0012115'>hepatitis</z:hpo> in cases and controls, adjusted for matching factors, race, duration of Medicare coverage, and number of physician claims </plain></SENT>
<SENT sid="4" pm="."><plain>HCV, HBV, and alcoholic <z:hpo ids='HP_0012115'>hepatitis</z:hpo> were reported in 195 (0.3%), 111 (0.2%), and 404 (0.7%) cases and 264 (0.2%), 242 (0.2%), and 798 (0.7%) controls, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>HCV was associated with increased risk of diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> [odds ratio (OR) 1.52, 95% confidence interval (95% CI) 1.05-2.18], Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (OR 5.21, 95% CI 1.62-16.8), follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (OR 1.88, 95% CI 1.17-3.02), marginal zone <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (OR 2.20, 95% CI 1.22-3.95), and <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (OR 1.54, 95% CI 1.00-2.37) </plain></SENT>
<SENT sid="6" pm="."><plain>In contrast, HBV was unrelated to any <z:e sem="disease" ids="C0376544" disease_type="Neoplastic Process" abbrv="">hematopoietic malignancies</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Alcoholic <z:hpo ids='HP_0012115'>hepatitis</z:hpo> was associated with decreased risk of non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> overall, but increased risk of Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>In summary, HCV, but not other causes of <z:hpo ids='HP_0012115'>hepatitis</z:hpo>, was associated with the elevated risk of non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>HCV may induce lymphoproliferative <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> through <z:hpo ids='HP_0011010'>chronic</z:hpo> immune stimulation </plain></SENT>
</text></document>